HA
AGN

Homestead Advisers’s Allergan plc AGN Stock Holding History

Homestead Advisers’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-349,307
Closed -$61.9M – 104
2020
Q1 		$61.9M Sell
349,307
-9,780
-3% -$1.84M 1.82% 22
2019
Q4 		$68.6M Sell
359,087
-3,471
-1% -$626K 1.43% 31
2019
Q3 		$61M Sell
362,558
-13,051
-3% -$2.13M 1.23% 34
2019
Q2 		$62.9M Hold
375,609
– – 1.19% 32
2019
Q1 		$55M Buy
+375,609
New +$54.5M 1.03% 32

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Homestead Advisers's AGN Position: Q2 2020 in Review

Homestead Advisers sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 349,307 shares — an estimated $61.9M sold.

Homestead Advisers first reported a position in AGN in Q1 2019 and held it in 5 quarters. The position peaked at $68.6M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Homestead Advisers reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Homestead Advisers sold 349,307 Allergan plc shares in Q2 2020, an estimated $61.9M.
  • Homestead Advisers first reported a position in Allergan plc in Q1 2019 and held it in 5 quarters.
  • Homestead Advisers's Allergan plc position peaked at $68.6M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Homestead Advisers's 13F filing for Q2 2020, filed 13 Aug 2020.